[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344876-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344876-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-expression-of-malat1-long-non-coding-rna-is-associated-with-good-prognosis-in-mantle-cell-lymphoma-research-findings","The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma - Research findings","","MALAT1 is a long non-coding RNA whose altered expression is linked to many cancers, yet its role in mantle cell lymphoma (MCL) has remained insufficiently studied. Using microarray data from 219 primary tumors, the study examines MALAT1 expression and its natural antisense transcript TALAM1, which is involved in MALAT1 RNA processing. High MALAT1/TALAM1 expression consistently associates with favorable clinical behavior independent of other known alterations. Functional analyses further show MALAT1 levels are reduced by microenvironmental stimuli and EZH2 activity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-expression-of-malat1-long-non-coding-rna-is-associated-with-good-prognosis-in-mantle-cell-lymphoma-research-findings/344876/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-expression-of-malat1-long-non-coding-rna-is-associated-with-good-prognosis-in-mantle-cell-lymphoma-research-findings/344876.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is MALAT1 and why was it studied in mantle cell lymphoma?","Question",{"text":63,"@type":64},"MALAT1 is a long non-coding RNA with altered expression in many cancers. The study investigates its role in mantle cell lymphoma, where lncRNA contributions are still poorly understood.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do MALAT1 and TALAM1 expression levels relate to MCL patient outcomes?",{"text":68,"@type":64},"Across three independent cohorts, higher MALAT1 or TALAM1 expression was linked to significantly longer overall survival and favorable clinical behavior in MCL.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence supports the biological regulation of MALAT1 in MCL?",{"text":72,"@type":64},"Functional studies in primary MCL samples indicate MALAT1 levels are downregulated by microenvironmental stimuli and EZH2 activity, an epigenetic factor associated with poor prognosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344876,1790356510,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma  \nElena María Fernández-Garnacho1, Cristina Martínez-Muñoz1, Ferran Nadeu1,2, Guillem Clot1,2,3, Juan GarcíaValero1,2, Ferran Araujo-Ayala1,2, Ares Martínez-Farran1, Anna De Bolòs1,2, Dolors Colomer1,2,4, Pablo Mozas1,4, Andrea Rivero1,4, Eva Giné1,2,4, Armando López-Guillermo1,2,4, Itziar Salaverria1,2, Cristina López1,2,4, Sílvia Beà1,2,4, Virginia Amador1,2, Santiago Demajo1, Pedro Jares1,2,5, José Ignacio Martín-Subero1,2,6, Patricia Pérez-Galán1,2, Elías Campo1,2,3,5 & Lluís Hernández1,2,7􀀍  \nMALAT1 is a long non-coding RNA (lncRNA) with altered expression in many cancers but poorly studied in B-cell neoplasms like mantle cell lymphoma (MCL), a very aggressive B-cell lymphoma. To elucidate the role of MALAT1 in MCL we have investigated its expression in 219 primary tumors using microarray data. We also analyzed the expression of its natural antisense transcript (TALAM1), which is key for the processing of MALAT1 RNA to its active isoform. High expression of MALAT1/TALAM1 lncRNAs was consistently linked to favorable clinical behavior in MCL, independently of other alterations previously described to influence MCL prognosis. In concordance with the observed clinical association, we found that the increased expression of these lncRNAs was inversely associated with gene signatures related to a proliferative and activation phenotype (MCL35-proliferation/BCR signaling signatures) in MCL samples from lymph nodes as peripheral blood. Finally, functional studies of MALAT1 in MCL primary samples showed that its levels were downregulated by microenvironmental stimuli and EZH2 activity, a known epigenetic factor induced by pro-proliferative stimuli and previously related with poor MCL prognosis. Altogether, these data support the favorable prognostic value of MALAT1 expression in MCL, and the MALAT1 dual role as oncogene or tumor suppressor in different neoplasms.  \nKeywords Long non-coding RNAs, MALAT1, TALAM1, Lymphoma, MCL, Biomarker  \nLong non-coding RNAs (lncRNAs) are key regulators ofthe expression of protein-coding genes and play critical roles in both physiological and pathological contexts, including cancer1,2. Among them, MALAT1 is one of the most frequently implicated lncRNAs in oncogenesis primarily through its involvement in the regulation of essential cellular pathways3. Consequently, MALAT1 has been associated with various cancer-related processes such as cell proliferation, migration, invasion, apoptosis and angiogenesis4.  \nTALAM1 is a natural antisense transcript at the MALAT1 locus which has been functionally related to positively regulate MALAT1 levels by promoting its 3′-end cleavage and maturation5. Although the clinical relevance of TALAM1 expression remains unexplored, preliminary studies in solid tumors have reported its induction specifically in tumor cells, and its cooperation with MALAT1 to determine cancer aggressiveness6,7. Multiple studies have described MALAT1 expression as a clinical biomarker, predominantly associated with poor prognosis in solid tumors3, and B-cell lymphomas (B-NHL), such as mantle cell lymphoma (MCL)8. However other reports have suggested that elevated MALAT1 levels may correlate with favorable outcomesin lymphoid neoplasms such as diffuse large B-cell lymphoma9–12. These seemingly contradictory findings  \n1Lymphoid Neoplasm Program, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. 2Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. 3Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain. 4Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain. 5Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain. 6Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelon","cbCaioMrvux6K4e9","https://ap.wps.com/l/cbCaioMrvux6K4e9","pdf",6202299,12,"English","# Results\n## MALAT1 and TALAM1 expression and prognosis in MCL\n## Clinical cohorts and survival association","[{\"question\":\"What is MALAT1 and why was it studied in mantle cell lymphoma?\",\"answer\":\"MALAT1 is a long non-coding RNA with altered expression in many cancers. The study investigates its role in mantle cell lymphoma, where lncRNA contributions are still poorly understood.\"},{\"question\":\"How do MALAT1 and TALAM1 expression levels relate to MCL patient outcomes?\",\"answer\":\"Across three independent cohorts, higher MALAT1 or TALAM1 expression was linked to significantly longer overall survival and favorable clinical behavior in MCL.\"},{\"question\":\"What experimental evidence supports the biological regulation of MALAT1 in MCL?\",\"answer\":\"Functional studies in primary MCL samples indicate MALAT1 levels are downregulated by microenvironmental stimuli and EZH2 activity, an epigenetic factor associated with poor prognosis.\"}]","The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma - Research findings | PDF",1790055523,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c710e75fc86910cba0dc073cc690338c.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a84efc21765e5e843f35f53f2ed2f95f.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba9a2cb812d02c8bef87fead24525737.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c395dbc5e843e5c131a8b038c338229f.webp",980,1287]